Categories
Uncategorized

Coronavirus: Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report

twitter.com/cancermedic/status/1558767321417744391

Leave a comment